Human purified CD8+ T cells: Ex vivo expansion model to generate a maximum yield of functional cytotoxic cells

Immunological Investigations

Volumn 36, Issue 1, 2007, Pages 85-104

  Al Shanti, Nasser ^a   Aldahoudi, Ziyad ^b  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^b KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Autologous feeders; Cytokines; Expansion; Human CD8+T cells

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 7;

ADOPTIVE IMMUNOTHERAPY; ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CELL CULTURE; CELL FUNCTION; CELL GROWTH; CONTROLLED STUDY; CYTOTOXICITY; EX VIVO STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOCYTE CULTURE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PURIFICATION;

ADULT; ANTIGENS, CD8; CD8-POSITIVE T-LYMPHOCYTES; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SYNERGISM; HUMANS; INTERLEUKIN-2; K562 CELLS; MODELS, IMMUNOLOGICAL; SERUM ALBUMIN; T-LYMPHOCYTES, CYTOTOXIC;

EID: 33845873837     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.1080/08820130600991950     Document Type: Article

References (48)

1. Alderson, M. R., Sassenfeld, H. M., Widmer, M. B. (1990). Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood. J. Exp. Med. 172:577-587.
2. Alves, N. L., Hooibrink, B., Arosa, F. A., van Lier, R. A. (2003). IL-15 induces antigen-independent expansion and differentiation of human naive CD8+T cells in vitro. Blood 102:2541-2546.
3. Azuma, M., Phillips, J. H., Lanier, L. L. (1993). CD28- T lymphocytes. Antigenic and functional properties. J Immunol. 150:1147-1159.
4. Brunda, M. J., Gately, M. K. (1994). Antitumor activity of interleukin-12. Clin. Immunol. Immunopathol. 71:253-255.
5. Carson, D. A. (1997). Unconventional T-cell activation by IL-15 in rheumatoid arthritis. Nat. Med. 3:148-149.
6. d'Angeac, A. D., Monier, S., Pilling, D., Travaglio-Encinoza, A., Reme, T., Salmon, M. (1994) CD57+ T lymphocytes are derived from CD57- precursors by differentiation occurring in late immune responses. Eur J Immunol. 24:1503-1511
7. Froelich, C. J., Orth, K., Turbov, J., Seth, P., Gottlieb, R., Babior, B., Shah, G. M., Bleackley, R. C., Dixit, V. M., Hanna, W. (1996). New paradigm for lymphocyte granule-mediated cytotoxicity. Target cells bind and internalize granzyme B, but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis. J. Biol. Chem. 271:29073-29079.
8. Fu, T. M., Freed, D. C., Trigona, W. L., Guan, L., Zhu, L., Long, R., Persaud, N. V., Manson, K., Dubey, S., Shiver, J. W. (2001). Evaluation of cytotoxic T-lymphocyte responses in human and nonhuman primate subjects infected with human immunodeficiency virus type 1 or simian/human immunodeficiency virus. J. Virol. 75:73-82.
9. Gombert, W., Borthwick, N. J., Wallace, D. L., Hyde, H., Bofill, M., Pilling, D., Beverley, P. C., Janossy, G., Salmon, M., Akbar, A. N. (1996). Fibroblasts prevent apoptosis of IL-2-deprived T cells without inducing proliferation: a selective effect on Bcl-XL expression. Immunology 89:397-404.
10. Groux, H., Bigler, M., de Vries, J. E., Roncarolo, M. G. (1998). Inhibitory and stimulatory effects of IL-10 on human CD8+T cells. J. Immunol. 160:3188-3193.
11. Gulzar, N., Copeland, K. F. (2004). CD8+T-cells: function and response to HIV infection. Curr HIV Res. 2:23-37.
12. Hamann, D., Roos, M. T., van Lier, R. A. (1999). Faces and phases of human CD8 T-cell development. Immunol. Today 20:177-180.
13. Hamann, D., Baars, P. A., Rep, M. H., Hooibrink, B., Kerkhof-Garde, S. R., Klein, M. R., van Lier, R. A. (1997). Phenotypic and functional separation of memory and effector human CD8+Tcells. J. Exp. Med. 186:1407-1418.
14. Hamann, D., Kostense, S., Wolthers, K. C., Otto, S. A., Baars, P. A., Miedema, F., van Lier, R. A. (1999). Evidence that human CD8+CD45RA+CD27- cells are induced by antigen and evolve through extensive rounds of division. Int Immunol. 11:1027-1033.
15. Imir, T., Gibbs, D. L., Sibbitt, W. L Jr, Bankhurst, A. D. (1985). Generation of natural killer cells and lymphokine-activated killer cells in human AB serum or fetal bovine serum. Clin. Immunol. Immunopathol. 36:289-296.
16. Lalvani, A., Dong, T., Ogg, G., Patham, A. A., Newell, H., Hill, A. V., McMichael, A. J., Rowland-Jones, S. (1997). Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors. J. Immunol. Meth. 210:65-77.
17. Lieberman, J. (2003). The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat. Rev. Immunol. 3:361-370.
18. Lynne, J. E. (1998). Major expansions of select CD8+ subsets in acute Epstein-Barr virus infection: comparison with chronic human immunodeficiency virus disease. J. Infect. Dis. 177:1083-1087.
19. Kambayashi, T., Assarsson, E., Chambers, B. J., Ljunggren, H. G. (2001). Cutting edge: Regulation of CD8 (+)T cell proliferation by 2B4/CD48 interactions. J. Immunol. 167:6706-67010.
20. Kutza, J., Murasko, D. M. (1996). Age-associated decline in IL-2 and IL-12 induction of LAK cell activity of human PBMC samples. Mech. Ageing Dev. 90:209-222.
21. Kutza, J., Murasko, D. M. (1994). Effects of aging on natural killer cell activity and activation by interleukin-2 and IFN-alpha. Cell Immunol. 155:195-204.
22. McNerney, M. E., Lee, K. M., Kumar, V. (2005). 2B4 (CD244) is a non-MHC binding receptor with multiple functions on natural killer cellsandCD8+Tcells. Mol. Immunol. 42:489-494. Review.
23. Mehrotra, P. T., Wu, D., Crim, J. A., Mostowski, H. S., Siegel, J. P. (1993). Effects of IL-12 on the generation of cytotoxic activity in human CD8+T lymphocytes. J. Immunol. 151:2444-2452.
24. Misko, I. S., Sculley, T. B., Schmidt, C., Moss, D. J., Soszynski, T., Burman, K. (1991). Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4 cytotoxic T cell clones and includes an Epstein-Barr virus-specific component. Cell Immunol. 132:295-307.
25. Misko, I. S., Soszynski, T. D., Kane, R. G., Pope, J. H. (1984). Factors influencing the human cytotoxic T cell response to autologous lymphoblastoid cell lines in vitro. Immunol. Immunopathol. 32:285-297.
26. +-T cells in vitro. Hum. Immunol. 61:357-366.
27. Pilling, D., Akbar, A. N., Girdlestone, J., Orteu, C. H., Borthwick, N. J., Amft, N., Scheel-Toellner, D., Buckley, C. D., Salmon, M. (1999). Interferon-beta mediates stromal cell rescue of T cells from apoptosis. Eur. J. Immunol. 29:1041-1050.
28. Rowbottom, A. W., Lepper, M. A., Garland, R. J., Cox, C. V., Corley, E. G. (1999). Interleukin-10-induced CD8 cell proliferation. Immunology 98:80-89.
29. Sallusto, F., Lenig, D., Forster, R., Lipp, M., Lanzavecchia, A. (1999). Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708-712.
30. Schendel, D. J., Oberneder, R., Falk, C. S., Jantzer, P., Kressenstein, S., Maget, B., Hofstetter, A., Riethmuller, G., Nossner, E. (1997). Cellular and molecular analyses of major histocompatibility complex (MHC) restricted and non-MHC-restricted effector cells recognizing renal cell carcinomas: problems and perspectives for immunotherapy. J. Mol. Med. 75:400-413.
31. Speiser, D. E., Colonna, M., Ayyoub, M., Cella, M., Pittet, M. J., Batard, P., Valmori, D., Guillaume, P., Lienard, D., Cerottini, J. C., Romero, P. (2001). The activatory receptor 2B4 is expressed in vivo by human CD8+ effector alpha beta T cells. J. Immunol. 167:6165-6170.
32. Stanciu, L. A., Roberts, K., Lau, L. C., Coyle, A. J., Johnston, S. L. (2001). Induction of type 2 activity in adult human CD8(+) T cells by repeated stimulation and IL-4. Int. Immunol. 13:341-348.
33. Sykulev, Y., Joo, M., Vturina, I., Tsomides, T. J., Eisen, H. N. (1996). Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 4:565-571.
34. Tan, J. T., Dudl, E., LeRoy, E., Murray, R., Sprent, J., Weinberg, K. I., Surh, C. D. (2001). IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci USA 98:8732-8737.
35. Theze, J., Alzari, P. M., Bertoglio, J. (1996). Interleukin 2 and its receptors: recent advances and new immunological functions. Immunol. Today 17:481-486.
36. Torsteinsdottir, S., Masucci, M. G., Brautbar, C., Lenoir, G., Klein, G., Klein, E. (1986). Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones. Cell Immunol. 98:453-466.
37. Trapani, J. A., Sutton, V. R., Thia, K. Y., Li, Y. Q., Froelich, C. J., Jans, D. A., Sandrin, M. S., Browne, K. A. (2003). A clathrin/dynamin- and mannose-6-phosphate receptor-independent pathway for granzyme B-induced cell death. J Cell Biol. 160:223-233.
38. Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A., Boon, T. (1992). A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med. 176:1453-1457.
39. Tussey, L., Speller, S., Gallimore, A., Vessey, R. (2000). Functionally distinct CD8+memory T cell subsets in persistent EBV infection are differentiated by migratory receptor expression. Eur. J. Immunol. 30:1823-1829.
40. Valmori, D., Dutoit, V., Lienard, D., Rimoldi, D., Pittet, M. J., Champagne, P., Ellefsen, K., Sahin, U., Speiser, D., Lejeune, F., Cerottini, J. C., Romero, P. (2000). Naturally occurring human lymphocyte antigen-A2 restricted CD8+T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients. Cancer Res. 60:4499-4506.
41. Van de Griend, R. J., Van Krimpen, B. A., Bol, S. J., Thompson, A., Bolhuis, R. L. (1984). Rapid expansion of human cytotoxic T cell clones: growth promotion by a heat-labile serum component and by various types of feeder cells. J. Immunol. Meth. 66:285-298.
42. Van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., Boon, T. (1991). A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643-1647.
43. Van Lier, R. A., ten Berge, I. J., Gamadia, L. E. (2003). Human CD8(+) T-cell differentiation in response to viruses. Nat. Rev. Immunol. 3:931-939.
44. + T lymphocytes in normal, healthy to human cytomegalovirus. J. Immunol. 155:5046-5056.
45. Yamaguchi, M., Hirayama, F., Murahashi, H., Azuma, H., Sato, N., Miyazaki, H., Fukazawa, K., Sawada, K., Koike, T., Kuwabara, M., Ikeda, H., Ikebuchi, K. (2002). Ex vivo expansion of human UC blood primitive hematopoietic progenitors and transplantable stem cells using human primary BM stromal cells and human AB serum. Cytotherapy.; 4:109-118.
46. Yang, Y. F., Tomura, M., Iwasaki, M., Mukai, T., Gao, P., Ono, S., Zou, J. P., Shearer, G. M., Fujiwara, H., Hamaoka, T. (2001). IL-12 as well as IL-2 upregulates CCR5 expression on T cell receptor-triggered human CD4+andCD8+Tcells. J. Clin. Immunol. 21:116-125.
47. Yee, C., Savage, P. A., Lee, P. P., Davis, M. M., Greenberg, P. D. (1999). Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. J. Immunol. 162:2227-2234.
48. Yewdell, J. W., Haeryfar, S. M. (2005). Understanding presentation of viral antigens to CD8+T cells in vivo: the key to rational vaccine design. Annu. Rev. Immunol. 23:651-682.